The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis
Deliang Guo(Wuhan University), Paul S. Mischel(University of California, Los Angeles), Julie Dang(Centre National de la Recherche Scientifique), Mary M. Mazzotta, Timothy F. Cloughesy(University of California, Los Angeles), Isabel J. Hildebrandt, Michael E. Phelps(National Academy of Engineering), Horacio Soto(University of California, Los Angeles), Andrew D. Watson, Robert M. Prins(University of California, Los Angeles), Johannes Czernin(University of California, Los Angeles), Caius G. Radu(APLA Health)
Cited by 235
Related Papers
Molecular Determinants of the Response of Glioblastomas to EGFR Kinase Inhibitors
|New England Journal of Medicine|2005|1.4k
Quantitation in Positron Emission Computed Tomography
|Journal of Computer Assisted Tomography|1979|1.2k
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma
|Proceedings of the National Academy of Sciences|2007|1.1k